GRMN
40
3
LOW
45
2
ADT
48
2
CNP
55
3
VIX
19
-2
TRIP
52
2
MHK
50
2
MAS
63
3
NEE
52
2
GS
78
2
EXPD
48
-2
D
45
4
RF
63
2
SWKS
56
8
HSIC
62
-3
PNW
57
2
HPE
68
-5
PX
55
2
COP
44
-3
CRM
59
-11
GRMN
40
3
LOW
45
2
ADT
48
2
CNP
55
3
VIX
19
-2
TRIP
52
2
MHK
50
2
MAS
63
3
NEE
52
2
GS
78
2
EXPD
48
-2
D
45
4
RF
63
2
SWKS
56
8
HSIC
62
-3
PNW
57
2
HPE
68
-5
PX
55
2
COP
44
-3
CRM
59
-11
Financhill
Back

State Street SPDR S&P Telecom ETF Vs. Travere Therapeutics, Inc. Industry Stock Comparison

Buy
84

XTL
State Street SPDR S&P Telecom ETF

Last Price:
$155.77
Seasonality Move:
0.59%
Buy
80

TVTX
Travere Therapeutics, Inc.

Last Price:
$40.3200
Seasonality Move:
33.23%
Buy
84
State Street SPDR S&P Telecom ETF (XTL) is a Buy

Is State Street SPDR S&P Telecom ETF a Buy, Sell or Hold?

  • The current State Street SPDR S&P Telecom ETF [XTL] share price is $155.55. The Score for XTL is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
  • XTL is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
80
Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Travere Therapeutics, Inc. [TVTX] share price is $40.2800. The Score for TVTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

XTL Stock Price Chart

What is State Street SPDR S&P Telecom ETF's stock price today?

  • The State Street SPDR S&P Telecom ETF share price today is $155.55
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XTL is experiencing selling pressure, which indicates risk of future bearish movement.

TVTX Stock Price Chart

What is Travere Therapeutics, Inc.'s stock price today?

  • The Travere Therapeutics, Inc. share price today is $40.2800
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.

XTL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 37.75 Buy
Relative Strength Index (14 RSI): 58.27 Buy
Chaikin Money Flow: -5157 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (141 - 154.34) Buy
Bollinger Bands (100): (132.22 - 151.18) Buy

TVTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.67 Buy
Relative Strength Index (14 RSI): 69.35 Buy
Chaikin Money Flow: 1508490 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.0318 - 36.4718) Buy
Bollinger Bands (100): (20.7309 - 34.2909) Buy

XTL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 150.85 Buy
20-day SMA: 150.18 Buy
50-day SMA: 148.01 Buy
200-day SMA: 123.72 Buy
8-day EMA: 109.24 Buy
20-day EMA: 59.76 Buy
50-day EMA: 27.45 Buy
200-day EMA: 7.37 Buy

TVTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.7 Buy
20-day SMA: 35.23 Buy
50-day SMA: 33.43 Buy
200-day SMA: 22.2 Buy
8-day EMA: 28.52 Buy
20-day EMA: 16.32 Buy
50-day EMA: 7.67 Buy
200-day EMA: 2.09 Buy

State Street SPDR S&P Telecom ETF Earnings Growth & XTL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.

State Street SPDR S&P Telecom ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Travere Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):